Telormedix Appoints Chief Financial Officer
Telormedix announced that it has appointed Phillipe Lutz as its new Chief Financial Officer.
Lutz joins Telormedix from Synosia Therapeutics where he has been Chief Financial Officer for the last two years. While at Synosia Therapeutics, he helped the Company close a CHF32 million Series B financing round, which was ranked as the largest private Swiss biotech financing in 2008. In addition, he managed the implementation of a holding structure and re-incorporation from the USA to Switzerland and built up Synosia’s Basel office. Previous to Synosia, he worked for nine years at Credit Suisse in Zurich contributing to a broad range of equity market transactions including a number of IPOs, ultimately attaining the position of Vice President of the Global Markets Solutions Group. While at Credit Suisse he successfully completed the chartered financial analyst exams (CFA). A Swiss national, Lutz received a Masters in Business Administration from the University of St. Gallen, where he majored in finance and capital markets.
Other news from the department people
